Logomix Biotechnology, Inc.
PrivateLast Round
Series A
Jul 30, 2025
Total Funding Raised
$24.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Logomix Biotechnology, Inc. is a synthetic biology company that develops a proprietary Geno-Writing™ platform for large-scale, precise genome engineering in human induced pluripotent stem cells (iPSCs) to support cell therapy and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Logomix Biotechnology, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Logomix Biotechnology, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 30, 2025 | ||||
| Grant | May 1, 2024 | ||||
| Seed | Feb 8, 2023 |
Logomix Biotechnology, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GLOBIS Capital Partners | Series A |
| JAFCO Group Co., Ltd. | Series A, Seed |
| MIRAISOZO INVESTMENTS Inc. | Series A |
| Angel Bridge | Series A, Seed |
| ITOCHU Technology Ventures | Series A |
| New Energy and Industrial Technology Development Organization | Grant |
| Norinchukin Capital Co., Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 77% MoM.
- Mar 3, 2026
Partnering with Belgian CDMO Bio Base Europe Pilot Plant.
Logomix Biotechnology, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Logomix Biotechnology, Inc.'s valuation, stock price, and market status.